Chronic kidney disease in the global adult HIV-infected population: A systematic review and meta-analysis-Reference-Cited by-同舟云学术

Chronic kidney disease in the global adult HIV-infected population: A systematic review and meta-analysis

Published:2018-04-16 Issue:4 Volume:13 Page:e0195443
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Ekrikpo Udeme E.,Kengne Andre P.,Bello Aminu K.,Effa Emmanuel E.,Noubiap Jean Jacques,Salako Babatunde L.,Rayner Brian L.,Remuzzi Giuseppe,Okpechi Ikechi G.^ORCID

Funder

PAMAPS

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference129 articles.

1. Worldwide access to treatment for end-stage kidney disease: a systematic review;T Liyanage;The Lancet,2015

2. A cross-sectional study of HIV-seropositive patients with varying degrees of proteinuria in South Africa;TM Han;Kidney international,2006

3. Microalbuminuria predicts overt proteinuria among patients with HIV infection;LA Szczech;HIV medicine,2010

4. Water, electrolytes, and acid-base alterations in human immunodeficiency virus infected patients;CG Musso;World journal of nephrology,2016

5. Incidence and risk factors for acute kidney injury in HIV Infection;Y Li;American journal of nephrology,2012

Cited by 120 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Subclinical atherosclerosis burden in carotid and femoral territories in HIV subjects: relationships with HIV and non-HIV related factors;BMC Infectious Diseases;2024-09-09

2. Prevalence and associations of chronic kidney disease among antiretroviral therapy-naïve persons living with HIV in Lagos, Nigeria;BMC Nephrology;2024-08-23

3. HIV-associated kidney disease: the changing spectrum and treatment priorities;Current Opinion in Nephrology & Hypertension;2024-08-20

4. Towards equitable renal care: Strategies for enhancing kidney transplantation in Africa;Journal of Medicine, Surgery, and Public Health;2024-08

5. Comparative Effectiveness of Switching to Bictegravir From Dolutegravir-, Efavirenz-, or Raltegravir-Based Antiretroviral Therapy Among Individuals With HIV Who are Virologically Suppressed;Open Forum Infectious Diseases;2024-07-30